$19.31
0.11[0.57%]
At close: Apr 19
$19.31
0[0.00%]
After Hours: 4:00PM EDT
Castle Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Castle Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | CSTL | Q1 | -$1.10 | -$0.32 | — | — | $42.04M | $65.81M | — | — | Get Alert |
02/28/2024 | PM | CSTL | Q4 | -$0.78 | -$0.54 | -$0.10 | 81.48% | $38.34M | $56.28M | $66.12M | 17.48% | Get Alert |
11/02/2023 | PM | CSTL | Q3 | -$0.77 | -$0.76 | -$0.26 | 65.79% | $37.01M | $48.52M | $61.49M | 26.74% | Get Alert |
08/02/2023 | PM | CSTL | Q2 | -$0.77 | -$1.01 | -$0.70 | 30.69% | $34.84M | $43.51M | $50.14M | 15.23% | Get Alert |
05/03/2023 | PM | CSTL | Q1 | -$0.97 | -$0.89 | -$1.10 | -23.60% | $26.85M | $37.37M | $42.04M | 12.49% | Get Alert |
02/28/2023 | PM | CSTL | Q4 | -$0.25 | -$0.84 | -$0.78 | 7.14% | $25.04M | $37.16M | $38.34M | 3.17% | Get Alert |
11/02/2022 | PM | CSTL | Q3 | -$0.44 | -$0.88 | -$0.77 | 12.50% | $23.48M | $34.75M | $37.01M | 6.51% | Get Alert |
08/08/2022 | PM | CSTL | Q2 | -$0.35 | -$0.76 | -$0.77 | -1.32% | $22.76M | $28.37M | $34.84M | 22.80% | Get Alert |
05/09/2022 | PM | CSTL | Q1 | -$0.17 | -$0.71 | -$0.97 | -36.62% | $22.81M | $25.21M | $26.85M | 6.51% | Get Alert |
02/28/2022 | PM | CSTL | Q4 | -$0.17 | -$0.47 | -$0.25 | 46.81% | $17.30M | $23.74M | $25.04M | 5.47% | Get Alert |
11/08/2021 | PM | CSTL | Q3 | -$0.23 | -$0.40 | -$0.47 | -17.50% | $15.22M | $22.97M | $23.48M | 2.20% | Get Alert |
08/09/2021 | PM | CSTL | Q2 | -$0.08 | -$0.37 | -$0.34 | 8.11% | $12.71M | $18.93M | $22.76M | 20.22% | Get Alert |
05/10/2021 | PM | CSTL | Q1 | $0.03 | -$0.24 | -$0.17 | 29.17% | $17.42M | $16.66M | $22.81M | 36.93% | Get Alert |
03/08/2021 | PM | CSTL | Q4 | $0.11 | -$0.12 | -$0.17 | -41.67% | $17.64M | $15.74M | $17.30M | 9.90% | Get Alert |
11/09/2020 | PM | CSTL | Q3 | $0.02 | -$0.11 | -$0.23 | -109.09% | $14.78M | $14.99M | $15.22M | 1.51% | Get Alert |
08/10/2020 | PM | CSTL | Q2 | -$1.05 | -$0.40 | -$0.08 | 80.00% | $10.74M | — | $12.71M | — | Get Alert |
05/11/2020 | PM | CSTL | Q1 | — | -$0.15 | $0.03 | 120.00% | — | $13.79M | $17.42M | 26.31% | Get Alert |
03/10/2020 | PM | CSTL | Q4 | — | -$0.20 | $0.11 | 155.00% | — | $11.73M | $17.64M | 50.34% | Get Alert |
11/11/2019 | PM | CSTL | Q3 | -$2.33 | -$0.30 | $0.02 | 106.67% | $11.10M | $9.45M | $14.78M | 56.35% | Get Alert |
Castle Biosciences (CSTL) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.10, which beat the estimate of $-0.54.
The Actual Revenue was $66.1M, which beat the estimate of $56.3M.
Browse earnings estimates, EPS, and revenue on all stocks.